INVIMA announced the activation of a new automated module within the InvimÁgil platform that enables the automatic issuance of Free Sale Certificates (Certificados de Venta Libre, CVL) for health-regulated products. This enhancement forms part of the authority’s broader digital transformation strategy aimed at modernizing regulatory procedures and improving interactions with regulated stakeholders.
InvimÁgil was initially launched in early 2024 as a central digital platform to streamline regulatory processes. Since its deployment, additional modules have been progressively incorporated to reduce processing times, enhance transparency, and expand access to digital regulatory services.
This update represents a significant procedural improvement for companies that export medicinal, biological, and other health-regulated products. The CVL is a document commonly required by foreign regulatory authorities to confirm that a product is authorized and freely marketed in Colombia.
By enabling automated validation and digital issuance, the new module reduces manual intervention and supports more efficient certificate management. This contributes to improved regulatory efficiency, shorter processing timelines, and greater predictability for companies engaged in international trade.
Key Highlights
- Automated CVL Module
Activation of a new InvimÁgil module that enables automatic generation of Free Sale Certificates. - Export-Oriented Impact
Improves export workflows for health-regulated products by enabling faster and more predictable certificate issuance. - Operational Efficiency
Reduces manual processing and administrative burden while enhancing traceability and consistency in certificate management. - Digital Transformation
Reinforces INVIMA’s digital transformation strategy by expanding the functional ecosystem of the InvimÁgil platform.
This update reflects INVIMA’s continued efforts to modernize regulatory operations and facilitate international market access through more agile and transparent digital processes.